Published in J Biol Chem on November 16, 2016
Studying protein dynamics in living cells. Nat Rev Mol Cell Biol (2001) 8.43
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med (2007) 7.87
The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science (2000) 6.17
Dynamic binding of histone H1 to chromatin in living cells. Nature (2000) 4.91
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control (2005) 4.29
Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A (1981) 4.12
Vitamin D: its role and uses in immunology. FASEB J (2001) 3.40
FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat Cell Biol (2001) 2.76
Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature (2000) 2.41
Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol Cell (2000) 2.33
The use of FRET imaging microscopy to detect protein-protein interactions and protein conformational changes in vivo. Curr Opin Struct Biol (2001) 2.09
Molecular mechanisms of vitamin D action. Calcif Tissue Int (2012) 2.06
Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev (2014) 2.01
1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology (1981) 1.95
RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development (2001) 1.85
Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Pract Res Clin Endocrinol Metab (2011) 1.66
Measuring protein mobility by photobleaching GFP chimeras in living cells. Curr Protoc Cell Biol (2003) 1.61
Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol Endocrinol (2000) 1.50
Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer (2002) 1.48
Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol (2014) 1.42
Phosphorylation of linker histone H1 regulates gene expression in vivo by mimicking H1 removal. Mol Cell (1999) 1.42
The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3). Endocrinol Metab Clin North Am (2010) 1.39
Vitamin D and cancer: current dilemmas and future research needs. Am J Clin Nutr (2008) 1.35
The retinoid X receptors and their ligands. Biochim Biophys Acta (2011) 1.32
A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formation. Proc Natl Acad Sci U S A (2002) 1.27
Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system. Urology (1997) 1.24
Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA. EMBO J (2011) 1.24
Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol Endocrinol (2002) 1.20
A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer. Br J Cancer (1998) 1.19
Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J Biol Chem (2005) 1.18
A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Breast Cancer Res (2004) 1.17
Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Cancer Res (2001) 1.16
Subcellular distribution of normal and mutant vitamin D receptors in living cells. Studies with a novel fluorescent ligand. J Biol Chem (1997) 1.16
Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha. J Clin Invest (1999) 1.16
Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Mol Endocrinol (2003) 1.16
Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. Mol Cancer Ther (2004) 1.15
Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr (2001) 1.15
Dimerization with retinoid X receptors promotes nuclear localization and subnuclear targeting of vitamin D receptors. J Biol Chem (2000) 1.13
Vitamin D and bone. Curr Osteoporos Rep (2012) 1.08
Functional evidence for retinoid X receptor (RXR) as a nonsilent partner in the thyroid hormone receptor/RXR heterodimer. Mol Cell Biol (2002) 1.05
Stress pathway activation induces phosphorylation of retinoid X receptor. J Biol Chem (2000) 1.05
Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties. Biochemistry (1998) 1.03
Vitamin D and the skin: Physiology and pathophysiology. Rev Endocr Metab Disord (2012) 1.03
The vitamin D analogue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res (2000) 1.03
Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Cancer Res (1996) 1.02
Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid. Carcinogenesis (2003) 1.02
Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer. Clin Cancer Res (2005) 1.01
Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands. J Biol Chem (2007) 1.00
Central role of VDR conformations for understanding selective actions of vitamin D(3) analogues. Steroids (2001) 0.97
Hormone-dependent translocation of vitamin D receptors is linked to transactivation. J Biol Chem (1999) 0.97
Vitamin D and prostate cancer. J Androl (2002) 0.97
Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. J Biol Chem (2005) 0.97
Immunocytology with microwave-fixed fibroblasts shows 1 alpha,25-dihydroxyvitamin D3-dependent rapid and estrogen-dependent slow reorganization of vitamin D receptors. J Cell Biol (1990) 0.96
The functional consequences of cross-talk between the vitamin D receptor and ERK signaling pathways are cell-specific. J Biol Chem (2004) 0.96
Phosphorylated and dephosphorylated linker histone H1 reside in distinct chromatin domains in Tetrahymena macronuclei. Mol Biol Cell (1995) 0.96
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition. Cancer Res (2005) 0.95
Localisation of vitamin D receptor in normal human duodenum and in patients with coeliac disease. Gut (1994) 0.91
Disruption of vitamin D receptor-retinoid X receptor heterodimer formation following ras transformation of human keratinocytes. J Biol Chem (1998) 0.91
Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes. Nutrients (2015) 0.90
Global enhancement of nuclear localization-dependent nuclear transport in transformed cells. FASEB J (2011) 0.89
Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells. J Cell Physiol (2010) 0.89
Treatment of myelodysplastic syndromes with retinoic acid and 1 alpha-hydroxy-vitamin D3 in combination with low-dose ara-C is not superior to ara-C alone. Results from a randomized study. The Scandinavian Myelodysplasia Group (SMG). Eur J Haematol (1990) 0.88
Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients. Nutr Cancer (2012) 0.87
Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha. PLoS One (2012) 0.86
Chemoprevention activity of 25-hydroxyvitamin D in the MMTV-PyMT mouse model of breast cancer. Cancer Prev Res (Phila) (2014) 0.84
Inhibition of tumor growth and angiogenesis by vitamin D3 agents in murine renal cell carcinoma. J Urol (1998) 0.84
Phase II study of doxercalciferol for the treatment of myelodysplastic syndrome. Leuk Lymphoma (2008) 0.83
Relative resistance to 1,25-dihydroxyvitamin D3 in a keratinocyte model of tumor progression. J Biol Chem (1992) 0.82
Multicenter phase II trial of vitamin K(2) monotherapy and vitamin K(2) plus 1alpha-hydroxyvitamin D(3) combination therapy for low-risk myelodysplastic syndromes. Leuk Res (2010) 0.82
Chemoprevention of liver carcinogenesis with retinoids: Basic and clinical aspects. Hepatol Res (2007) 0.81
A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors. Invest New Drugs (2010) 0.81
The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling. Mol Pharmacol (2000) 0.81
Vitamin D resistance in RAS-transformed keratinocytes: mechanism and reversal strategies. Radiat Res (2001) 0.81
Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion. Mol Cancer Res (2002) 0.81
Inflammatory mediators increase SUMOylation of retinoid X receptor α in a c-Jun N-terminal kinase-dependent manner in human hepatocellular carcinoma cells. Mol Pharmacol (2013) 0.81
Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors. J Tissue Eng Regen Med (2013) 0.78
Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial. Cancer Epidemiol Biomarkers Prev (2014) 0.77
Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia. Anticancer Drugs (1995) 0.77
Retinoid X receptor alpha is highly phosphorylated in retinoic acid-resistant HL-60R cells and the combination of 9-cis retinoic acid plus MEK inhibitor induces apoptosis in the cells. Leuk Res (2007) 0.77
Tumoral Vitamin D Synthesis by CYP27B1 1-α-Hydroxylase Delays Mammary Tumor Progression in the PyMT-MMTV Mouse Model and Its Action Involves NF-κB Modulation. Endocrinology (2016) 0.76